Schiff Gordon D, Galanter William L, Duhig Jay, Lodolce Amy E, Koronkowski Michael J, Lambert Bruce L
Center for Patient Safety Research and Practice, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Arch Intern Med. 2011 Sep 12;171(16):1433-40. doi: 10.1001/archinternmed.2011.256. Epub 2011 Jun 13.
Judicious prescribing is a prerequisite for safe and appropriate medication use. Based on evidence and lessons from recent studies demonstrating problems with widely prescribed medications, we offer a series of principles as a prescription for more cautious and conservative prescribing. These principles urge clinicians to (1) think beyond drugs (consider nondrug therapy, treatable underlying causes, and prevention); (2) practice more strategic prescribing (defer nonurgent drug treatment; avoid unwarranted drug switching; be circumspect about unproven drug uses; and start treatment with only 1 new drug at a time); (3) maintain heightened vigilance regarding adverse effects (suspect drug reactions; be aware of withdrawal syndromes; and educate patients to anticipate reactions); (4) exercise caution and skepticism regarding new drugs (seek out unbiased information; wait until drugs have sufficient time on the market; be skeptical about surrogate rather than true clinical outcomes; avoid stretching indications; avoid seduction by elegant molecular pharmacology; beware of selective drug trial reporting); (5) work with patients for a shared agenda (do not automatically accede to drug requests; consider nonadherence before adding drugs to regimen; avoid restarting previously unsuccessful drug treatment; discontinue treatment with unneeded medications; and respect patients' reservations about drugs); and (6) consider long-term, broader impacts (weigh long-term outcomes, and recognize that improved systems may outweigh marginal benefits of new drugs).
合理用药是安全、恰当使用药物的前提。基于近期研究中有关广泛使用药物存在问题的证据和经验教训,我们提出一系列原则,作为更谨慎、保守用药的准则。这些原则敦促临床医生:(1) 跳出药物范畴思考(考虑非药物治疗、可治疗的潜在病因和预防措施);(2) 采用更具策略性的用药方法(推迟非紧急药物治疗;避免不必要的换药;对未经证实的药物用途保持谨慎;每次仅开始一种新药治疗);(3) 对不良反应保持高度警惕(怀疑药物反应;了解撤药综合征;并教育患者预期反应);(4) 对新药保持谨慎和怀疑态度(寻找客观信息;等到药物在市场上有足够时间;对替代指标而非真正的临床结果持怀疑态度;避免扩大适应症;避免被精妙的分子药理学所迷惑;警惕药物试验报告的选择性);(5) 与患者共同制定用药计划(不要自动同意患者的用药请求;在增加药物治疗方案前考虑患者依从性;避免重新开始之前未成功的药物治疗;停用不必要的药物治疗;尊重患者对药物的保留意见);以及(6) 考虑长期、更广泛的影响(权衡长期结果,并认识到改善系统可能比新药的边际效益更重要)。